CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s stock price hit a new 52-week high on Tuesday . Weiss Ratings reiterated a “sell (d-)” rating on shares of CG Oncology in a research report on Friday, July 17th. Get CG Oncology alerts:Read Our Latest Stock Report on CG OncologyCG Oncology Stock Down 0.5%The business’s fifty day moving average is $67.47 and its 200 day moving average is $64.17. CG Oncology (NASDAQ:CGON – Get Free Report) last issued its earnings results on Thursday, August 6th. Further ReadingReceive News & Ratings for CG Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CG Oncology and related companies with MarketBeat.com's FREE daily email newsletter.